Literature DB >> 2925608

Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.

J J Seilhamer1, W Pruzanski, P Vadas, S Plant, J A Miller, J Kloss, L K Johnson.   

Abstract

Synovial fluid from arthritic patients contains multiple forms of phospholipase A2 (PLA2), as resolved by high performance liquid chromatography (Seilhamer, J.J., Plant, S., Pruzanski, W., Schilling, J., Stefanski, E., Vadas, P., and Johnson, L. K. (1989) J. Biochem. (Tokyo), submitted for publication). Here we describe the cloning of a human 4.5-kilobase gene and 800-base pair cDNA encoding the form representing the major peak of activity and protein mass (peak A). The clones encode a mature peptide of 124 amino acids, which follows a prepeptide of 20 residues. The deduced amino acid sequence constitutes an enzyme of the "Type II" class of PLA2s, and resembles PLA2s from other mammalian sources. This represents the first report of a full length mammalian non-pancreatic PLA2 sequence. Active transcription of this PLA2 gene was detected in two different inflammatory cell sources. Recombinant human peak A PLA2 was expressed in vaccinia as a secreted protein which accumulated in conditioned medium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2925608

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

1.  Total chemical synthesis of enzymatically active human type II secretory phospholipase A2.

Authors:  T M Hackeng; C M Mounier; C Bon; P E Dawson; J H Griffin; S B Kent
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Inhibitory Effect of FXa on Secretory Group IIA Phospholipase A2.

Authors:  Sae-Kwang Ku; Jong-Sup Bae
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

3.  Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.

Authors:  W Pruzanski; K Scott; G Smith; I Rajkovic; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

4.  Unusually high conservation of untranslated sequences in cDNAs for Trimeresurus flavoviridis phospholipase A2 isozymes.

Authors:  T Ogawa; N Oda; K Nakashima; H Sasaki; M Hattori; Y Sakaki; H Kihara; M Ohno
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

5.  A simple and sensitive method for determining transcription initiation site: identification of two transcription initiation sites in rat group II phospholipase A2 gene.

Authors:  O Ohara; J Ishizaki; T Nakano; H Arita; H Teraoka
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

6.  Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.

Authors:  Mario Menschikowski; Albert Hagelgans; Heike Kostka; Graeme Eisenhofer; Gabriele Siegert
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

7.  Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.

Authors:  A N Fonteh; J M Samet; F H Chilton
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

8.  Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene.

Authors:  T Wu; T Ikezono; C W Angus; J H Shelhamer
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

9.  Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.

Authors:  I Lilja; K Smedh; G Olaison; R Sjödahl; C Tagesson; C Gustafson-Svärd
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

10.  Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.

Authors:  Rob C Oslund; Nathan Cermak; Christophe L M J Verlinde; Michael H Gelb
Journal:  Bioorg Med Chem Lett       Date:  2008-09-12       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.